Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients

MLA

B.C. Agema, et al. “Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients.” Annals of Oncology, vol. 30, Oct. 2019, p. v768. EBSCOhost, https://doi.org/10.1093/annonc/mdz268.020.

APA

B.C. Agema, S.L. Koolen, M. De With, N. Heersche, N. van Doorn, E. Oomen-de Hoop, S. Visser, J.G. Aerts, S. Bins, R.H.N. van Schaik, & R.H. Mathijssen. (2019). Influence of genetic variation in COMT on cisplatin-induced nephrotoxicity in cancer patients. Annals of Oncology, 30, v768. https://doi.org/10.1093/annonc/mdz268.020

Chicago

B.C. Agema, S.L. Koolen, M. De With, N. Heersche, N. van Doorn, E. Oomen-de Hoop, S. Visser, et al. 2019. “Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients.” Annals of Oncology 30 (October): v768. doi:10.1093/annonc/mdz268.020.